Paediatric Allergy Action Plans
The Paediatric Allergy Group (PAG) has updated its Allergy Action Plans for children at risk of anaphylaxis. These plans have been designed to facilitate first aid treatment of anaphylaxis, to be delivered by people without any special medical training nor equipment apart from access to an adrenaline autoinjector (AAI).
The updated plans are designed to function as Individual Healthcare Plans for children with food allergies, providing medical and parental consent for schools to administer medicines in the event of an allergic reaction. This includes consent to administer a “spare” back-up adrenaline auto-injector pen which schools are able to purchase under changes to the Human Medicines (Amendment) Regulations 2017, with effect from 1 October 2017.